Related Experiment Videos
Technology transfer of neuroprosthetic devices
P H Peckham1, G Thrope, J Woloszko
1VA Cleveland FES Center, Cleveland VA Medical Center, OH 44106-3052, USA.
Journal of Rehabilitation Research and Development
|April 1, 1996
Summary
Neuroprosthetic device development is increasing, with lessons learned from regulatory processes. Incorporating user needs and addressing person-technology mismatches are key for successful clinical application and rehabilitation outcomes.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Rehabilitation Medicine
Background:
- The clinical use and trial numbers for neuroprosthetic devices are growing, with approximately 3,000 systems currently in use.
- Developers are gaining experience with regulatory pathways, such as the United States Food and Drug Administration (FDA) approval process for neuroprostheses.
- The development of the first FDA-approved motor prosthesis offers valuable insights for companies navigating regulatory hurdles.
Purpose of the Study:
- To outline key considerations for the successful development and clinical integration of neuroprosthetic devices.
- To emphasize the importance of user-centered design throughout the neuroprosthesis development lifecycle.
- To identify strategies for maximizing device adoption and individual usage in clinical settings.
Main Methods:
- Reviewing the regulatory approval process for neuroprosthetic devices.
- Analyzing the development trajectory of the first FDA-approved motor prosthesis.
- Examining customer (physician, surgeon, therapist, end-user) feedback and preferences in device design.
- Investigating methods to optimize device utilization and address person-technology mismatches.
Main Results:
- Regulatory approval processes are becoming more understood by developers.
- Incorporating customer capabilities and preferences into neuroprosthesis design is crucial.
- Strategies are needed to maximize both the breadth of users and the depth of use for neuroprosthetic devices.
- Identifying and mitigating person-technology mismatches can improve rehabilitation outcomes.
Conclusions:
- Successful neuroprosthetic device development requires continuous engagement with end-users and regulatory bodies.
- Optimizing device design and implementation strategies are essential for widespread clinical adoption.
- Addressing individual user needs and potential mismatches is critical for achieving positive rehabilitation results with neuroprosthetic technologies.